packageIpriflavone

ipriflavone

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Ipriflavone, an isoflavone derivative, has been studied for the treatment of bone diseases such as osteoporosis. It remains an investigational drug and is not an approved medicine in the European Union.

Summary written by glm-5.3-flash from Wikidata Q1097778 and the WHO ATC classification; not checked by a person.

name:ipriflavone
ATC codes:M05BX01
DrugBank:DB13618
PubChem CID:3747
ChEBI:31719
Wikidata:Q1097778
formula:C18H16O3
molar mass:280.323 g/mol (PubChem CID 3747)
logP:4 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown